TABLE 3.
Multivariable analysis of factors associated with guideline-concordant adjuvant therapy in patients with resected pathologic T1–3 pN1–2 M0 non-small cell lung cancer
| Odds ratio | 95% confidence interval (lower, upper) | P value | |
|---|---|---|---|
| Age (per decade) | 0.53 | (0.50, 0.57) | <.001 |
| Year of diagnosis (ref = 2006) | 1.11 | (1.09, 1.13) | <.001 |
| Female sex | 1.04 | (0.95, 1.13) | .44 |
| Race (ref = white) | |||
| Black | 1.00 | (0.85, 1.18) | .99 |
| Other | 0.90 | (0.70, 1.15) | .41 |
| Charlson Comorbidity Score (ref = 0) | |||
| 1 | 0.97 | (0.88, 1.07) | .53 |
| 2+ | 0.90 | (0.79, 1.03) | .14 |
| Education (per quartile) | 1.07 | (1.01, 1.14) | .02 |
| Income (per quartile) | 1.05 | (0.99, 1.11) | .09 |
| Insurance status (ref = private) | |||
| Medicare/Medicaid | 0.90 | (0.81, 1.01) | .07 |
| Other government | 0.64 | (0.42, 0.99) | .04 |
| Unknown | 1.23 | (0.76, 1.99) | .40 |
| Uninsured | 0.54 | (0.40, 0.72) | <.001 |
| AJCC pathologic T stage | 1.06 | (0.99, 1.12) | .10 |
| AJCC pathologic N2 (vs Nl) | 1.67 | (1.50, 1.86) | <.001 |
| Pneumonectomy (vs lobectomy) | 0.78 | (0.68, 0.89) | <.001 |
| Length of stay (per day) | 0.96 | (0.95, 0.96) | <.001 |
| Readmission | 0.60 | (0.49, 0.72) | <.001 |
| Facility type (ref = community) | |||
| Comprehensive community program | 1.00 | (0.84, 1.19) | .99 |
| Research/academic program | 0.91 | (0.76, 1.10) | .32 |
AJCC, American Joint Committee on Cancer.